In October it was reported that Washington Redskins Cheerleader Desiree Jennings suffered from a neurological condition, dystonia, brought on by the seasonal flu shot. Jennings had difficulty speaking, walking, and experienced frequent seizures. Jennings is now recovering despite previous reports that indicated she would not.

In a story reported last week, NFL cheerleader, Desiree Jennings, suffers from a neurological illness called dystonia that was brought on by the seasonal flu shot she received in August. In response to her story, celebrities Jim Carrey and Jenny McCarthy reached out to Desiree with information abouth their organization, Generation Rescue.

The Centers for Disease Control have reported 86 deaths of children since the new H1N1 virus, commonly called the swine flu, arose last spring. Of those 86, half of them were reported in September and early October alone, and there have been 11 reported in the last week.

The debate over how safe the flu shot is appears in the news several times a week. In general, there are more risks in getting the flu itself than there are in the vaccine. However, the news that NFL cheerleader, Desiree Jennings, now suffers from a neurological condition brought on by the flu shot is causing fear in many people.

People suffering from the flu may be at higher risk for having a heart attack a new study reports.

Vaccine against H1N1 Swine Flu has been approved by FDA, which brings a rejuvenating spree in countries suffering from the pandemic.

Some infectious disease experts say that the alarm being created for swine flu could be unwarranted.

A team of Princeton University scientists may have found a better way to make a vaccine against the flu virus. Though theoretical, the work points to the critical importance of what has been a poorly appreciated aspect of the interaction between a flu virus and those naturally produced defensive proteins called antibodies that fight infection.

A new computerized method of testing could help world health officials better identify flu vaccines that are effective against multiple strains of the disease. Rice University scientists who created the method say tests of data from bird flu and seasonal flu outbreaks suggest their method can better gauge the efficacy of proposed vaccines than can tests used today.

Giving people age 65 and older a dose four times larger than the standard flu vaccine boosts the amount of antibodies in their blood to levels considered protective against the flu, more so than the standard flu vaccine does. The findings from a study of nearly 4,000 people were presented Oct. 26 at a national meeting on infectious diseases.